OL
VRTX icon

Optas LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Optas LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576K Hold
1,160
– – 0.08% 154
2026
Q1 		$518K Buy
1,160
+125
+12% +$58.3K 0.08% 155
2025
Q4 		$469K Buy
1,035
+271
+35% +$117K 0.07% 184
2025
Q3 		$299K Sell
764
-143
-16% -$59.8K 0.05% 253
2025
Q2 		$404K Sell
907
-875
-49% -$403K 0.08% 168
2025
Q1 		$864K Buy
1,782
+908
+104% +$423K 0.15% 74
2024
Q4 		$352K Buy
874
+64
+8% +$29.7K 0.08% 153
2024
Q3 		$377K Buy
810
+37
+5% +$17.8K 0.09% 141
2024
Q2 		$362K Buy
773
+19
+3% +$8.25K 0.09% 119
2024
Q1 		$315K Buy
754
+9
+1% +$3.81K 0.09% 135
2023
Q4 		$303K Buy
745
+10
+1% +$3.69K 0.09% 134
2023
Q3 		$256K Buy
735
+19
+3% +$6.64K 0.09% 139
2023
Q2 		$252K Buy
716
+9
+1% +$3.03K 0.08% 137
2023
Q1 		$223K Buy
+707
New +$212K 0.08% 144
2020
Q4 		– Sell
-1,351
Closed -$367K – 174
2020
Q3 		$367K Buy
1,351
+469
+53% +$129K 0.11% 112
2020
Q2 		$256K Sell
882
-135
-13% -$36.6K 0.1% 103
2020
Q1 		$241K Buy
1,017
+9
+0.9% +$2.06K 0.12% 111
2019
Q4 		$220K Buy
+1,008
New +$204K 0.08% 140

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Optas LLC's VRTX Position: Q2 2026 in Review

Optas LLC held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,160 shares worth $576K. The position accounts for 0.08% of the portfolio, ranked #154.

Optas LLC first reported a position in VRTX in Q4 2019 and has held it in 18 quarters since. The position peaked at $864K in Q1 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Optas LLC held 1,160 shares of Vertex Pharmaceuticals worth $576K as of Q2 2026.
  • Optas LLC left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.08% of Optas LLC's portfolio in Q2 2026, its #154 holding.
  • Optas LLC first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 18 quarters since.
  • Optas LLC's Vertex Pharmaceuticals position peaked at $864K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.